Cargando…
Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
Many studies have focused on identifying therapeutic targets of myocardial hypertrophy for the treatment of correlative cardiac events. Wogonin is a natural flavonoid compound that displays a potent anti-hypertrophic effect. Knowledge of its pharmacological mechanisms might reveal an effective way t...
Autores principales: | Qian, Weichun, Yu, Dongsheng, Zhang, Jia, Hu, Qiaoyun, Tang, Chuanfeng, Liu, Peiyu, Ye, Peng, Wang, Xiaoli, Lv, Qiu, Chen, Minglong, Sheng, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099096/ https://www.ncbi.nlm.nih.gov/pubmed/30150938 http://dx.doi.org/10.3389/fphar.2018.00896 |
Ejemplares similares
-
Isosteviol prevents the development of isoprenaline-induced myocardial hypertrophy
por: Chen, Yaoxu, et al.
Publicado: (2019) -
Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway
por: Zhang, Tianli, et al.
Publicado: (2022) -
A Mixture of Baicalein, Wogonin, and Oroxylin-A Inhibits EMT in the A549 Cell Line via the PI3K/AKT-TWIST1-Glycolysis Pathway
por: Cao, Hui-Juan, et al.
Publicado: (2022) -
Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway
por: Li, Yu, et al.
Publicado: (2023) -
Network Pharmacology for Analyzing the Key Targets and Potential Mechanism of Wogonin in Gliomas
por: Wang, Zaizhong, et al.
Publicado: (2021)